Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001662426-26-000004

Director acquired 2,954 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Morrison Scott W Director 2026-06-12 Option exercise +2,954 7,638 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Morrison Scott W Director 2026-06-12 Option exercise · Restricted Stock Units −2,954 0 D: show line 2 in the form
Loading xslF345X06/wk-form4_1781640402.xml…